Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Hisse Senetlerindeki Sıralama
#4957
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Hisse Fiyatı
$2.47
Piyasa Değeri
$2.95B
Değişim (1 gün)
-1.22%
Değişim (1 yıl)
-14.21%
Ülke
CN
Ticaret Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Kategori
Healthcare
Jilin Aodong Pharmaceutical Group Co., Ltd. (000623) için temettü verimi geçmişi
Jilin Aodong Pharmaceutical Group Co., Ltd. (hisse sembolü: 000623) temettü verimi (TTM) 2023-12-31 itibariyle: 1.98%
Son 5 yılın ortalama temettü verimi: 2.30%
Son 5 yılın ortalama temettü verimi: 2.30%
Jilin Aodong Pharmaceutical Group Co., Ltd. (000623) için 2000 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
| Yıl | Temettü Verimi | Değiştir |
|---|---|---|
| 2026 (TTM) | 2.92% | -43.95% |
| 2024 | 5.21% | 163.13% |
| 2023 | 1.98% | -1.49% |
| 2022 | 2.01% | 86.11% |
| 2021 | 1.08% | -11.48% |
| 2020 | 1.22% | 0.83% |
| 2019 | 1.21% | -42.38% |
| 2018 | 2.10% | 103.88% |
| 2017 | 1.03% | -4.63% |
| 2016 | 1.08% | 50.00% |
| 2015 | 0.72% | 148.28% |
| 2014 | 0.29% | -52.46% |
| 2013 | 0.61% | -32.22% |
| 2012 | 0.90% | 1,185.71% |
| 2011 | 0.07% | -87.04% |
| 2010 | 0.54% | 42.11% |
| 2009 | 0.38% | 245.45% |
| 2008 | 0.11% | 22.22% |
| 2007 | 0.09% | -70.97% |
| 2006 | 0.31% | -96.53% |
| 2005 | 8.94% | 410.86% |
| 2004 | 1.75% | -61.54% |
| 2003 | 4.55% | 189.81% |
| 2002 | 1.57% | -46.60% |
| 2001 | 2.94% | 366.67% |
| 2000 | 0.63% | 0.00% |
Benzer şirketler veya rakiplerin temettü verimi (TTM)
| Şirket | Temettü Verimi | Ülke |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
